COVID-19 and ischemic stroke

Area of Science:

• Neurology
• Infectious Diseases
• Cardiovascular Medicine

Background:

• The COVID-19 pandemic has seen a significant rise in thrombotic complications among patients.
• Ischemic stroke is a notable complication, impacting patient outcomes and healthcare systems.
• Potential mechanisms include immune responses, renin-angiotensin system alterations, and direct SARS-CoV-2 effects on tissues.

Purpose of the Study:

• To review the current understanding of ischemic stroke in COVID-19 patients.
• To bridge the gap between basic science research and clinical practice.
• To provide insights relevant to managing stroke during the global health crisis.

Main Methods:

• Literature review of existing studies on COVID-19 and ischemic stroke.
• Synthesis of epidemiological data, clinical manifestations, and pathophysiological mechanisms.
• Analysis of challenges in stroke management within the context of the pandemic.

Main Results:

• COVID-19 is associated with an increased incidence of thrombotic events and ischemic stroke.
• Multiple interconnected mechanisms contribute to stroke pathogenesis in COVID-19.
• Healthcare systems faced unprecedented challenges in managing stroke patients during the pandemic.

Conclusions:

• Understanding the multifaceted nature of ischemic stroke in COVID-19 is crucial.
• Integrated approaches are needed to address both the viral infection and cerebrovascular complications.
• This review provides a foundation for improved clinical strategies and future research.